Your account is not claimed yet. You can sign up with ORCID to claim your account.

Belinda Yeo

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Topics

Early Breast Cancer

Top Venues

Science advances

Clinical cancer research : an official journal of the American Association for Cancer Research

Mediators of inflammation

Journal of the Endocrine Society

Austin Health

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Austin Health

Australia

Medical Oncologist

Publications

David W Cescon, John Hilton, Serafin Morales Murillo, Rachel M Layman, Timothy J Pluard, Belinda Yeo, In Hae Park, Louise Provencher, Sung-Bae Kim, Young-Hyuck Im, Anastasia Wyce, Anu Shilpa Krishnatry, Kirsty Hicks, Qu Zhang, Olena Barbash, Ahmed Khaled, Thierry Horner, Arindam Dhar, Mafalda Oliveira, Joseph A Sparano
A Phase I/II Study of GSK525762 Combined With Fulvestrant in Patients With Hormone Receptor-Positive/HER2-Negative (HR+/HER2-) Advanced or Metastatic Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jean Berthelet, Verena C Wimmer, Holly J Whitfield, Antonin Serrano, Thomas Boudier, Stefano Mangiola, Michal Merdas, Farrah El-Saafin, David Baloyan, Jordan Wilcox, Steven Wilcox, Adam C Parslow, Anthony T Papenfuss, Belinda Yeo, Matthias Ernst, Bhupinder Pal, Robin L Anderson, Melissa J Davis, Kelly L Rogers, Frédéric Hollande, Delphine Merino
The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile. Science advances 7 (28) (2021)
Yee-Ming Cheung, Sabashini K Ramchand, Belinda Yeo, Mathis Grossmann
Cardiometabolic Effects of Endocrine Treatment of Estrogen Receptor-Positive Early Breast Cancer. Journal of the Endocrine Society 3 (7) (2019)
Riley J Morrow, Nima Etemadi, Belinda Yeo, Matthias Ernst
Challenging a Misnomer? The Role of Inflammatory Pathways in Inflammatory Breast Cancer. Mediators of inflammation 2017 (2017)